Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial

BACKGROUND: Large field irradiation had been standard for early-stage follicular lymphoma (FL) for a long time. Although involved field radiotherapy (IF-RT) was recently favored because of the toxicity of large field irradiation, smaller irradiation fields have been accompanied with an increased ris...

Descripción completa

Detalles Bibliográficos
Autores principales: König, Laila, Dreyling, Martin, Dürig, Jan, Engelhard, Marianne, Hohloch, Karin, Viardot, Andreas, Witzens-Harig, Mathias, Kieser, Meinhard, Klapper, Wolfram, Pott, Christiane, Herfarth, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717383/
https://www.ncbi.nlm.nih.gov/pubmed/31470902
http://dx.doi.org/10.1186/s13063-019-3614-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717383/
https://www.ncbi.nlm.nih.gov/pubmed/31470902
http://dx.doi.org/10.1186/s13063-019-3614-y

Ejemplares similares